home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 03/28/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows | Benzinga

A recent study suggests that despite Novo Nordisk A/S’s (NYSE:NVO) high monthly charge of close to $1,000 for its blockbuster diabe...
Insurance Coverage For Weight Loss Drugs - Elevance, CVS Health Become First To Extend Coverage To Novo Nordisk's Successful Wegovy For Certain Patients | Benzinga

Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV), and Kaiser Permanente wil...

Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk's Weight Loss Sensation Wegovy | Benzinga

Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV) and Kaiser Permanente, will start reimburs...

Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly | Benzinga

Monday, Biohaven’s (NYSE:BHVN) CEO, Vlad Coric, joined CNBC Fast Money to discuss the weight loss drug wars and the company...
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In' | Benzinga

Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer. &quo...

How Are Obesity Drugs And Nvidia Related? Success Of Ozempic, Wegovy Propels Novo Nordisk Foundation To Fund Nvidia-Powered AI Supercomputer For Faster Drug Development | Benzinga

Novo Nordisk A/S (NYSE:NVO), the maker of popular diabetes and weight loss drugs like Ozempic and Wegovy, is delving into artificial intellige...

Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge | Benzinga

Scores of patients are reportedly taking legal action against pharmaceutical giants Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S...
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health | Benzinga

In a significant development, Medicare may extend coverage for Novo Nordisk A/S’s (NYSE:NVO) weight-loss drug Wegovy (sem...

Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions | Benzinga

Eli Lilly and Co. (NYSE:LLY) enjoyed meteoric success with its weight loss drugs Mounjaro and Zepbound — the latter already recording stellar sal...

Novo Nordisk Stock Stalls On Oprah TV Special, But Reddit Traders Believe It's 'Not Done Yet' | Benzinga

Retail investors are talking about a slim group of topics on Reddit this week including Novo Nordisk A/S (NYSE:NVO), weight-loss drug Ozempic and t...
Previous 10 Next 10